BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

BD and Mitsubishi Gas Chemical Have Signed a Letter Of Intent (LOI) to Discuss a Partnership Agreement to Explore New Ways to Advance Biologic Drug Delivery

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. ...

May 18, 2022 | News

New therapeutic option to reduce risk of cardiovascular deaths and repeated hospitalizations among adult heart failure patients approved in Singapore

Over the course of the VICTORIA study, there was a 4.2% reduction in annualized absolute risk with VERQUVO™ (vericiguat) compared with pl...

May 18, 2022 | News

Fujitsu and RIKEN start joint research on next-generation IT drug discovery technology using the supercomputer Fugaku and simulation integrated AI

The joint research project will leverage high performance computing technologies and the supercomputer Fugaku to accelerate simulation integrated AI that c...

May 17, 2022 | News

GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia

GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter referred to as "GeneQuantum"), a global innovative biotechnology company dedicated to the deve...

May 16, 2022 | News

A novel universal antiviral drug introduced in Korea

The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antiviral agent, developed ...

May 13, 2022 | News

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines

The 2022 CSCO Guidelines incorporate a total of four selinexor combination therapy regimens for relapsed myeloma. In addition, the guidelines also recommen...

May 13, 2022 | News

TIKOMED and IQVIA announce a strategic collaboration

Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead ...

May 06, 2022 | News

BD to Showcase its Deep Commitment to Drug Delivery Excellence at Pharmapack

The return to in-person meetings provides us with the opportunity to welcome you back to the BD booth -- which will show our wide range of services an...

May 04, 2022 | News

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the FDA for an EV...

April 28, 2022 | News

Lynk Pharmaceuticals Announces Clinical Approval in China for Its Class I New Drug LNK01004

LNK01004 is a novel kinase inhibitor that can simultaneously inhibit multiple inflammatory cytokines and block multiple signaling pathways related to psori...

April 25, 2022 | News

Terran Biosciences announces licensing deal with Sanofi

Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commer...

April 22, 2022 | News

BENDIT Technologies Receives U.S. Food and Drug Administration 510(k) Clearance of its Bendit 021" steerable microcatheter

The clearance was received several months after the successful first use of the Bendit21 neuro catheter in the USA in two life-saving procedures....

April 19, 2022 | News

CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information

This integration allows users to visualize and share plasmid information such as maps and sequences within the web-based CDD Vault application. Snap...

April 18, 2022 | News

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...

April 07, 2022 | News

Stay Connected